This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Element Biosciences files US complaint against Illumina over DNA sequencers

( September 22, 2025, 18:33 GMT | Official Statement) -- MLex Summary: Element Biosciences filed a US complaint accusing Illumina of illegally monopolizing the market for DNA sequencing instruments. According to the complaint, Illumina uses exclusivity agreements, coerces customers into buying new Illumina short-read NGS instruments by threatening punitive pricing on NGS consumables and instrument services for preexisting NGS instruments, and anticompetitively prices instruments below an appropriate measure of marginal cost through direct and bundled discounts.See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections